UNRESECTABLE OSTEOSARCOMA
Clinical trials for UNRESECTABLE OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to control aggressive bone cancer in young patients
Disease control Recruiting nowThis study tests two drugs, atezolizumab and cabozantinib, in 40 adolescents and young adults (ages 12 and up) with osteosarcoma that has come back or spread. Atezolizumab helps the immune system attack cancer cells, while cabozantinib blocks enzymes that help tumors grow. The go…
Matched conditions: UNRESECTABLE OSTEOSARCOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New drug cocktail aims to keep childhood cancers at bay
Disease control Recruiting nowThis phase 2 trial tests whether a year-long maintenance regimen of sirolimus (rapamycin) plus low-dose oral chemotherapy and celecoxib can improve 2-year survival without cancer progression in children with high-risk solid tumors. About 55 children and young adults (ages 1–30) w…
Matched conditions: UNRESECTABLE OSTEOSARCOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC